系统性审查显示FDA对抗抑郁药物的黑盒警告可能导致心理健康护理减少和青少年自杀增加. Systematic review shows that FDA's black box warnings on antidepressants may have led to reduced mental health care and increased youth suicide.
发表在《健康事务》杂志上的一项系统评价表明，FDA 针对抗抑郁药的黑框警告旨在减少青少年自杀倾向，可能适得其反。 A systematic review published in Health Affairs indicates that the FDA's black box warnings on antidepressants, aimed at reducing youth suicidality, may have backfired. 研究发现,心理健康护理下降,抑郁症医生出诊次数减少,青少年中精神药物中毒和自杀死亡增加。 The study found declines in mental health care, fewer doctor visits for depression, and increases in psychotropic drug poisonings and suicide deaths among youth. 研究人员建议FDA重新评估这些警告, 建议将它们纳入常规警告或完全删除. Researchers recommend that the FDA reevaluate these warnings, suggesting they could be incorporated into routine warnings or removed entirely.